Correction To: ARNTL Hypermethylation Promotes Tumorigenesis and Inhibits Cisplatin Sensitivity by Activating CDK5 Transcription in Nasopharyngeal Carcinoma
Overview
Overview
Journal
J Exp Clin Cancer Res
Publisher
Biomed Central
Specialty
Oncology
Date
2022 Jan 22
PMID
35062998
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Peng H, Zhang J, Zhang P, Chen L, Tang L, Yang X
. ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2019; 38(1):11.
PMC: 6325889.
DOI: 10.1186/s13046-018-0997-7.
View